Search
for
Sort by
Research 901–930 of 1000+
- Are 2D:4D finger-length ratios an indicator of androgenetic alopecia in males?
- Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
- Androgen receptor CAG repeat length is associated with ovarian reserve but not with ovarian response
- Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial
- Quantitative analysis of 34 sex (pro)hormones, conjugates and bioactive oxidation products thereof in human plasma by GC- and LC-MS/MS and systematic investigation of overestimations of analyte concentrations not accounted for by method validation
- Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
- Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives
- Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial
- Optical Coherence Tomography Angiography Findings in Polycystic Ovary Syndrome
- Changes in Prolactin and Insulin Resistance in PCOS Patients Undergoing Metformin Treatment: A Retrospective Study
- Hyperandrogenic Symptoms Are a Persistent Suffering in Midlife Women with PCOS; a Prospective Cohort Study in Sweden
- Collagen, Curcumin, and Glutathione to Enhance Dermal Health in Aging Women with Declining Estrogen Levels -A Narrative Review.
- Assessment of adipokines, hormonal profile, lipid profile, and insulin resistance in patients with androgenetic alopecia
- Pathophysiology, conventional treatments, and evidence-based herbal remedies of hair loss with a systematic review of controlled clinical trials
- Drug-associated gingival disorders: a retrospective pharmacovigilance assessment using disproportionality analysis
- Exploring links between acne and metabolic syndrome: a narrative review
- Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies
- A Study of Serum Ferritin and Thyroid-Stimulating Hormone Levels in Male Patients with Androgenetic Alopecia
- Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
- The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption
- Design, Synthesis, and Biological Characterization of Metabolically Stable Selective Androgen Receptor Modulators
- Association of Suicidality and Depression With 5α-Reductase Inhibitors
- Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Hair restoration surgery: challenges and solutions
- Post-finasteride syndrome: An emerging clinical problem
- Morphometric-stereological and functional epididymal alterations and a decrease in fertility in rats treated with finasteride and after a 30-day post-treatment recovery period
- Molecular Basis of Androgenetic Alopecia
- Ashwagandha root in the treatment of non-classical adrenal hyperplasia
- Treatment Advances for Acne Vulgaris: The Scientific Role of Cannabinoids